Vimarsana
Biggest News Aggregation in the World

Page 2 - Mark Posno News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Posno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Posno Today - Breaking & Trending Today

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gen - Vimarsana News

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gen

LEIDEN, the Netherlands, June 15, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of its premium 2G UNic™ technology for boosting therapeutic protein production to GenScript ProBio, a global contract...

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio - Vimarsana News

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio

/PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of...

ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies - Vimarsana News

ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies

ProteoNic and NecstGen announce a partnership for the development of improved viral vector manufacturing for gene therapy applications. Both companies, located on the Leiden Bio Science Park, recognise the need to increase viral titres and optimise production processes.

ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Ge - Vimarsana News

ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Ge

LEIDEN, the Netherlands, April 26, 2022 / B3C newswire / -- ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and centre of excellence for Cell and Gene Therapy, announce a partnership for the development of improved viral vector manuf...

ProteoNic and NecstGen establish partnership to improve viral vector manufacturing efficiency for Gene Therapies - Vimarsana News

ProteoNic and NecstGen establish partnership to improve viral vector manufacturing efficiency for Gene Therapies

/PRNewswire/ -- ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and centre...